The effects of SPCA1 deficiency is consistent with a model in which species differences in the balance between pro-survival and pro-apoptotic responses of keratinocytes to secretory pathway stress favor development of cancer in mice and acantholytic skin disease in humans. The gene discussed is ATP2C1; the disease is cancer.